MedTrace Logo

Induction of Donor Specific Tolerance in Recipients of Cardiac Allografts by Donor Stem Cell Infusion

NCT00497757 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2020-08-31

No results posted yet for this study

Summary

The goal of this research study is to establish chimerism and avoid graft-versus-host disease in patients who need a heart transplant.

Conditions

  • Heart Transplantation

Interventions

BIOLOGICAL

enriched hematopoetic stem cell infusion

Enriched Hematopoetic Stem Cell Infusion

Sponsors & Collaborators

  • Suzanne T. Ildstad

    lead OTHER

Principal Investigators

  • Suzanne T Ildstad, MD · University of Louisville

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-07-31
Primary Completion
2011-11-07
Completion
2016-12-01
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00497757 on ClinicalTrials.gov